The in vitro and in vivo results show that the MNAzyme-based nanomachine can strongly regulate HSP and PTEN expression and lead to significant pancreatic tumor inhibition under laser irradiation. The gene discussed is HSP90B2P; the disease is pancreatic neoplasm.